BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kasi PM, Grothey A. Chemotherapy-Induced Neutropenia as a Prognostic and Predictive Marker of Outcomes in Solid-Tumor Patients. Drugs 2018;78:737-45. [PMID: 29754293 DOI: 10.1007/s40265-018-0909-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Gennigens C, De Cuypere M, Seidel L, Hermesse J, Barbeaux A, Forget F, Albert A, Jerusalem G, Kridelka F. Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy. Cancer Med 2020;9:8432-43. [PMID: 32954675 DOI: 10.1002/cam4.3465] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kazama H, Kawaguchi O, Seto T, Suzuki K, Matsuyama H, Matsubara N, Tajima Y, Fukao T. Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer. BMC Cancer 2022;22:470. [PMID: 35484517 DOI: 10.1186/s12885-022-09509-0] [Reference Citation Analysis]
3 Gargiulo P, Arenare L, Gridelli C, Morabito A, Ciardiello F, Gebbia V, Maione P, Spagnuolo A, Palumbo G, Esposito G, Della Corte CM, Morgillo F, Mancuso G, Di Liello R, Gravina A, Schettino C, Di Maio M, Gallo C, Perrone F, Piccirillo MC. Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials. BMC Cancer 2021;21:549. [PMID: 33985435 DOI: 10.1186/s12885-021-08323-4] [Reference Citation Analysis]
4 Chen Y, Wang YR, Deng GC, Dai GH. CA19-9 decrease and survival according to platelet level in patients with advanced pancreatic cancer.BMC Cancer. 2019;19:860. [PMID: 31470818 DOI: 10.1186/s12885-019-6078-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Shahzad MH, Feng L, Su X, Brassard A, Dhoparee-Doomah I, Ferri LE, Spicer JD, Cools-Lartigue JJ. Neutrophil Extracellular Traps in Cancer Therapy Resistance. Cancers (Basel) 2022;14:1359. [PMID: 35267667 DOI: 10.3390/cancers14051359] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Nomura M, Morita Y, Kakiuchi A, Ishida K, Iizuka M, Yagi Y, Jobu K, Miyamura M. The association between chemotherapy-induced febrile neutropenia and breast cancer subtype in Japanese patients. Int J Clin Pharm 2020;42:7-10. [PMID: 31865592 DOI: 10.1007/s11096-019-00952-x] [Reference Citation Analysis]
7 Okunaka M, Kano D, Matsui R, Kawasaki T, Uesawa Y. Comprehensive Analysis of Chemotherapeutic Agents That Induce Infectious Neutropenia. Pharmaceuticals (Basel) 2021;14:681. [PMID: 34358105 DOI: 10.3390/ph14070681] [Reference Citation Analysis]
8 Hofmeister EN, Fisher S, Palesh O, Innominato PF. Does circadian rhythm influence gastrointestinal toxicity? Current Opinion in Supportive & Palliative Care 2020;14:120-6. [DOI: 10.1097/spc.0000000000000498] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Sarma K, Kohns DJ, Berri MA, Joyce E, Smith SR. Interventional and Non-interventional Medical Rehabilitation Approaches to Axial Spine Pain in Vertebral Metastatic Disease. Front Pain Res (Lausanne) 2021;2:675787. [PMID: 35295460 DOI: 10.3389/fpain.2021.675787] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Surendran V, Rutledge D, Colmon R, Chandrasekaran A. A novel tumor-immune microenvironment (TIME)-on-Chip mimics three dimensional neutrophil-tumor dynamics and neutrophil extracellalar traps (NETs)- mediated collective tumor invasion. Biofabrication 2021. [PMID: 33524968 DOI: 10.1088/1758-5090/abe1cf] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sereno M, Jimenez-Gordo AM, Baena-Espinar J, Aguado C, Mielgo X, Pertejo A, Álvarez-Álvarez R, Sánchez A, López JL, Molina R, López-Alfonso A, Hernández B, Chiara LE, Martín AM, López-Martín A, Dorta M, Collazo-Lorduy A, Casado E, de Molina AR, Colmenarejo G. A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis. Cancers (Basel) 2021;13:4205. [PMID: 34439359 DOI: 10.3390/cancers13164205] [Reference Citation Analysis]
12 Corso CR, Mulinari Turin de Oliveira N, Maria-Ferreira D. Susceptibility to SARS-CoV-2 infection in patients undergoing chemotherapy and radiation therapy. J Infect Public Health 2021;14:766-71. [PMID: 34022735 DOI: 10.1016/j.jiph.2021.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Liu Y, Cao Y, Xiao L, Wang H. Early myelostimulation in patients with locally advanced gastric cancer after fluorouracil plus platinum-based neoadjuvant chemotherapy is related to poor prognosis. Cancer Chemother Pharmacol 2021;87:701-10. [PMID: 33611625 DOI: 10.1007/s00280-021-04243-z] [Reference Citation Analysis]
14 Hannarici Z, Yılmaz A, Buyukbayram ME, Turhan A, Tekin SB, Bilici M. Lipegfilgrastim may cause hyperleukocytosis. J Oncol Pharm Pract 2022;:10781552221082645. [PMID: 35200056 DOI: 10.1177/10781552221082645] [Reference Citation Analysis]
15 Kasi PM, Grothey A. Should we optimize cytotoxic therapy by dosing to neutropenia? Lessons from TAS-102. Ann Oncol 2020;31:15-6. [PMID: 31912790 DOI: 10.1016/j.annonc.2019.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]